Literature DB >> 16767386

Leber's hereditary optic neuropathy precipitated by ethambutol.

Asako Ikeda1, Tomohiro Ikeda, Naohiro Ikeda, Yoshimi Kawakami, Osamu Mimura.   

Abstract

BACKGROUND: Leber's hereditary optic neuropathy (LHON) predominantly affects young men between 10 and 30 years of age. However, two cases of LHON during ethambutol administration have been reported in older men and one case in an older woman. We now report a second case of an older woman in whom administration of ethambutol triggered the development of LHON. CASE: A 70-year-old woman received ethambutol, rifampicin, isoniazid, and pyrazinamide for the treatment of tuberculosis. OBSERVATIONS: Three months after the beginning of this treatment, a marked decrease in visual acuity occurred in both eyes and ethambutol was discontinued. Her corrected visual acuity was 0.03 in both eyes. There was no hyperemia, swelling of the optic disc, or capillary dilatation in either eye. Centrocecal scotomas were found bilaterally. After 1 month, her visual acuity had further decreased to 0.01, and the scotomas had enlarged. At this time, genetic analysis revealed a point mutation in mitochondrial DNA 11778.
CONCLUSIONS: Ethambutol can be a risk factor for LHON because the number of reported ethambutol-related LHON cases has increased to four, including the present one. Ethambutol administration to patients with a family history of LHON should be avoided.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16767386     DOI: 10.1007/s10384-005-0308-7

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN: 0021-5155            Impact factor:   2.447


  5 in total

1.  Optic neuropathy after treatment with anti-tuberculous drugs in a subject with Leber's hereditary optic neuropathy mutation.

Authors:  M De Marinis
Journal:  J Neurol       Date:  2001-09       Impact factor: 4.849

2.  Leber's hereditary optic neuropathy mutations in ethambutol-induced optic neuropathy.

Authors:  Jeong-Min Hwang; Jiyeon Kim; Sung Sup Park
Journal:  J Neurol       Date:  2003-01       Impact factor: 4.849

3.  A case of ethambutol-induced optic neuropathy harbouring the primary mitochondrial LHON mutation at nt 11778.

Authors:  M T Dotti; K Plewnia; E Cardaioli; L Manneschi; A Rufa; G Alemà; A Federico
Journal:  J Neurol       Date:  1998-05       Impact factor: 4.849

Review 4.  Leber hereditary optic neuropathy.

Authors:  P Yu-Wai-Man; D M Turnbull; P F Chinnery
Journal:  J Med Genet       Date:  2002-03       Impact factor: 6.318

Review 5.  Leber hereditary optic neuropathy: respiratory chain dysfunction and degeneration of the optic nerve.

Authors:  N Howell
Journal:  Vision Res       Date:  1998-05       Impact factor: 1.886

  5 in total
  6 in total

1.  Risk factors for ethambutol optic toxicity.

Authors:  Katherine Anne Talbert Estlin; Alfredo A Sadun
Journal:  Int Ophthalmol       Date:  2009-02-11       Impact factor: 2.031

Review 2.  Mitochondrial optic neuropathies - disease mechanisms and therapeutic strategies.

Authors:  Patrick Yu-Wai-Man; Philip G Griffiths; Patrick F Chinnery
Journal:  Prog Retin Eye Res       Date:  2010-11-26       Impact factor: 21.198

3.  Leber's Hereditary Optic Neuropathy.

Authors:  Alfredo A Sadun; Chiara La Morgia; Valerio Carelli
Journal:  Curr Treat Options Neurol       Date:  2011-02       Impact factor: 3.598

4.  Sulthiame impairs mitochondrial function in vitro and may trigger onset of visual loss in Leber hereditary optic neuropathy.

Authors:  Marie-Christine Reinert; David Pacheu-Grau; Claudia B Catarino; Thomas Klopstock; Andreas Ohlenbusch; Michael Schittkowski; Ekkehard Wilichowski; Peter Rehling; Knut Brockmann
Journal:  Orphanet J Rare Dis       Date:  2021-02-04       Impact factor: 4.123

5.  Ethambutol-induced conversion in Leber's hereditary optic neuropathy: 6 years follow-up.

Authors:  Mayur R Moreker; Tanuj R Sharma; Satish V Khadilkar
Journal:  Indian J Ophthalmol       Date:  2022-07       Impact factor: 2.969

6.  Leber Hereditary Optic Neuropathy Associated with Bilateral Macular Holes.

Authors:  Yoshiaki Shimada; Masayuki Horiguchi
Journal:  Neuroophthalmology       Date:  2016-03-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.